MedPath

Effect of herbal extract mixture on treatment of diabetes

Phase 2
Conditions
Diabetes.
Non-insulin-dependent diabetes mellitus
E10, E14,
Registration Number
IRCT201503071157N10
Lead Sponsor
Vice chancellor for research, Institute of Medicinal Plants
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Type 2 diabetic patients; aged 40 to 60 years; fasting blood glucose levels from 130 to 160 mg/dL; blood glycosylated hemoglobin levels from 7.5 to 8.5 percent; under oral anti-hyperglycemic drugs therapy taking maximum1000 mg metformin and 10 mg glybencalamid daily. Exclusion criteria: Patients receiving insulin therapy; patients with cardiovascular, renal, hepatic, hematological, hypothyroidism, vertigo and seizure diseases; patients with a history of gallstones or gallbladder surgery; patients under estrogen, steroid, beta-blocker and thiazide therapy; women planning for pregnancy; pregnant women; breast-feeding women.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glucose. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood glucose level will be determined in laboratory by commercial standard kit.;Glycosylated hemoglobin (HbA1c). Timepoint: At starting of the study and after 3 months. Method of measurement: HbA1c percent will be determined in laboratory by commercial standard kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath